Selected research
Market Structure
Global Longum Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Longum market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Longum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Longum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Longum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Longum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Longum include ATCC Inc, BioCare Copenhagen ApS, Biofodan A/S, BioGaia AB, Danisco A/S, Danone SA, Deerland Enzymes Inc, Hanson Ltd and Mystic Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Longum market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Longum and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Longum sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Longum market size, projected growth trends, production technologies, key applications, and end-use industries.
Longum Segment by Company
ATCC Inc
BioCare Copenhagen ApS
Biofodan A/S
BioGaia AB
Danisco A/S
Danone SA
Deerland Enzymes Inc
Hanson Ltd
Mystic Pharmaceuticals Inc
Longum Segment by Type
0.2g/Piece
0.25g/Piece
Longum Segment by Application
Medicine
Others
Longum Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Longum market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Longum and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Longum.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Longum market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Longum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Longum in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Longum in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.2g/Piece
- 0.25g/Piece
Applications
- Medicine
- Others
Companies covered
- ATCC Inc
- BioCare Copenhagen ApS
- Biofodan A/S
- BioGaia AB
- Danisco A/S
- Danone SA
- Deerland Enzymes Inc
- Hanson Ltd
- Mystic Pharmaceuticals Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Longum Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Longum Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Longum Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Longum Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Longum Market Dynamics
- 2.1 Longum Industry Trends
- 2.2 Longum Industry Drivers
- 2.3 Longum Industry Opportunities and Challenges
- 2.4 Longum Industry Restraints
3 Longum Market by Manufacturers
- 3.1 Global Longum Revenue by Manufacturers (2021-2026)
- 3.2 Global Longum Sales by Manufacturers (2021-2026)
- 3.3 Global Longum Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Longum Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Longum Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Longum Manufacturers, Product Type & Application
- 3.7 Global Longum Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Longum Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Longum Players Market Share by Revenue in 2025
- 3.8.3 2025 Longum Tier 1, Tier 2, and Tier 3
4 Longum Market by Type
- 4.1 Longum Type Introduction
- 4.1.1 0.2g/Piece
- 4.1.2 0.25g/Piece
- 4.2 Global Longum Sales by Type
- 4.2.1 Global Longum Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Longum Sales by Type (2021-2032)
- 4.2.3 Global Longum Sales Market Share by Type (2021-2032)
- 4.3 Global Longum Revenue by Type
- 4.3.1 Global Longum Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Longum Revenue by Type (2021-2032)
- 4.3.3 Global Longum Revenue Market Share by Type (2021-2032)
5 Longum Market by Application
- 5.1 Longum Application Introduction
- 5.1.1 Medicine
- 5.1.2 Others
- 5.2 Global Longum Sales by Application
- 5.2.1 Global Longum Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Longum Sales by Application (2021-2032)
- 5.2.3 Global Longum Sales Market Share by Application (2021-2032)
- 5.3 Global Longum Revenue by Application
- 5.3.1 Global Longum Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Longum Revenue by Application (2021-2032)
- 5.3.3 Global Longum Revenue Market Share by Application (2021-2032)
6 Global Longum Sales by Region
- 6.1 Global Longum Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Longum Sales by Region (2021-2032)
- 6.2.1 Global Longum Sales by Region (2021-2026)
- 6.2.2 Global Longum Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Longum Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Longum Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Longum Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Longum Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Longum Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Longum Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Longum Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Longum Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Longum Revenue by Region
- 7.1 Global Longum Revenue by Region
- 7.1.1 Global Longum Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Longum Revenue by Region (2021-2026)
- 7.1.3 Global Longum Revenue by Region (2027-2032)
- 7.1.4 Global Longum Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Longum Revenue (2021-2032)
- 7.2.2 North America Longum Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Longum Revenue (2021-2032)
- 7.3.2 Europe Longum Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Longum Revenue (2021-2032)
- 7.4.2 Asia-Pacific Longum Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Longum Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Longum Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 ATCC Inc
- 8.1.1 ATCC Inc Company Information
- 8.1.2 ATCC Inc Business Overview
- 8.1.3 ATCC Inc Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 ATCC Inc Longum Product Portfolio
- 8.1.5 ATCC Inc Recent Developments
- 8.2 BioCare Copenhagen ApS
- 8.2.1 BioCare Copenhagen ApS Company Information
- 8.2.2 BioCare Copenhagen ApS Business Overview
- 8.2.3 BioCare Copenhagen ApS Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 BioCare Copenhagen ApS Longum Product Portfolio
- 8.2.5 BioCare Copenhagen ApS Recent Developments
- 8.3 Biofodan A/S
- 8.3.1 Biofodan A/S Company Information
- 8.3.2 Biofodan A/S Business Overview
- 8.3.3 Biofodan A/S Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Biofodan A/S Longum Product Portfolio
- 8.3.5 Biofodan A/S Recent Developments
- 8.4 BioGaia AB
- 8.4.1 BioGaia AB Company Information
- 8.4.2 BioGaia AB Business Overview
- 8.4.3 BioGaia AB Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 BioGaia AB Longum Product Portfolio
- 8.4.5 BioGaia AB Recent Developments
- 8.5 Danisco A/S
- 8.5.1 Danisco A/S Company Information
- 8.5.2 Danisco A/S Business Overview
- 8.5.3 Danisco A/S Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Danisco A/S Longum Product Portfolio
- 8.5.5 Danisco A/S Recent Developments
- 8.6 Danone SA
- 8.6.1 Danone SA Company Information
- 8.6.2 Danone SA Business Overview
- 8.6.3 Danone SA Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Danone SA Longum Product Portfolio
- 8.6.5 Danone SA Recent Developments
- 8.7 Deerland Enzymes Inc
- 8.7.1 Deerland Enzymes Inc Company Information
- 8.7.2 Deerland Enzymes Inc Business Overview
- 8.7.3 Deerland Enzymes Inc Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Deerland Enzymes Inc Longum Product Portfolio
- 8.7.5 Deerland Enzymes Inc Recent Developments
- 8.8 Hanson Ltd
- 8.8.1 Hanson Ltd Company Information
- 8.8.2 Hanson Ltd Business Overview
- 8.8.3 Hanson Ltd Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Hanson Ltd Longum Product Portfolio
- 8.8.5 Hanson Ltd Recent Developments
- 8.9 Mystic Pharmaceuticals Inc
- 8.9.1 Mystic Pharmaceuticals Inc Company Information
- 8.9.2 Mystic Pharmaceuticals Inc Business Overview
- 8.9.3 Mystic Pharmaceuticals Inc Longum Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Mystic Pharmaceuticals Inc Longum Product Portfolio
- 8.9.5 Mystic Pharmaceuticals Inc Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Longum Value Chain Analysis
- 9.1.1 Longum Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Longum Production Mode & Process
- 9.2 Longum Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Longum Distributors
- 9.2.3 Longum Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst